Clinical Trial Update: Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating opioids for refractory breathlessness in chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Dyspnea

Snippet

Sponsor: Flinders University | Conditions: Chronic Obstructive Pulmonary Disease, Dyspnea | Phase 3 | Status: WITHDRAWN